COSCIENS Biopharma Inc.
CSCI
$3.46
-$0.09-2.54%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 16.39M | 27.80M | 29.55M | 29.55M | 6.68M |
| Total Receivables | 2.47M | 1.36M | 308.00K | 308.00K | 290.00K |
| Inventory | 2.69M | 3.06M | 64.00K | 64.00K | 4.01M |
| Prepaid Expenses | 1.70M | 4.00K | 1.28M | 1.28M | 81.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 726.00K | 990.00K | -- | -- | 209.00K |
| Total Current Assets | 23.98M | 33.21M | 31.20M | 31.20M | 11.27M |
|
|
|||||
| Total Current Assets | 23.98M | 33.21M | 31.20M | 31.20M | 11.27M |
| Net Property, Plant & Equipment | 10.97M | 11.50M | 271.00K | 271.00K | 11.65M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00 | 3.34M | -- | -- | 7.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 123.00K | 2.00M | 326.00K | 326.00K | 826.00K |
| Total Assets | 35.07M | 50.05M | 31.79M | 31.79M | 23.75M |
|
|
|||||
| Total Accounts Payable | 2.41M | 3.59M | 2.40M | 2.40M | 281.00K |
| Total Accrued Expenses | 2.37M | 2.26M | 1.91M | 1.91M | 731.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 271.00K | 407.00K | 154.00K | 154.00K | 299.00K |
| Total Finance Division Other Current Liabilities | 2.17M | 3.65M | 783.00K | 783.00K | -- |
| Total Other Current Liabilities | 2.17M | 3.65M | 783.00K | 783.00K | -- |
| Total Current Liabilities | 7.22M | 9.90M | 5.25M | 5.25M | 1.31M |
|
|
|||||
| Total Current Liabilities | 7.22M | 9.90M | 5.25M | 5.25M | 1.31M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.04M | 1.28M | 80.00K | 80.00K | 1.40M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 12.65M | 12.64M | 13.49M | 13.49M | -- |
| Total Liabilities | 21.91M | 23.82M | 18.82M | 18.82M | 2.71M |
|
|
|||||
| Common Stock & APIC | 22.49M | 22.00M | 293.41M | 293.41M | 13.52M |
| Retained Earnings | -12.11M | 1.53M | -375.26M | -375.26M | 4.36M |
| Treasury Stock & Other | 2.79M | 2.69M | 94.82M | 94.82M | 3.16M |
| Total Common Equity | 13.16M | 26.23M | 12.97M | 12.97M | 21.04M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 13.16M | 26.23M | 12.97M | 12.97M | 21.04M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 13.16M | 26.23M | 12.97M | 12.97M | 21.04M |
|
|
|||||